ATE419234T1 - Substituierte pyrrole, zusammensetzungen, die diese enthalten, verfahren zur ihrer herstellung und ihre verwendung - Google Patents

Substituierte pyrrole, zusammensetzungen, die diese enthalten, verfahren zur ihrer herstellung und ihre verwendung

Info

Publication number
ATE419234T1
ATE419234T1 AT06709274T AT06709274T ATE419234T1 AT E419234 T1 ATE419234 T1 AT E419234T1 AT 06709274 T AT06709274 T AT 06709274T AT 06709274 T AT06709274 T AT 06709274T AT E419234 T1 ATE419234 T1 AT E419234T1
Authority
AT
Austria
Prior art keywords
production
compositions containing
containing same
substituted pyrroles
pyrroles
Prior art date
Application number
AT06709274T
Other languages
English (en)
Inventor
Baptiste Ronan
Michel Tabart
Catherine Souaille
Fabrice Viviani
Eric Bacque
Jean-Philippe Lettalec
Pascal Desmazeau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE419234(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE419234T1 publication Critical patent/ATE419234T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06709274T 2005-02-10 2006-02-08 Substituierte pyrrole, zusammensetzungen, die diese enthalten, verfahren zur ihrer herstellung und ihre verwendung ATE419234T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
ATE419234T1 true ATE419234T1 (de) 2009-01-15

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06709274T ATE419234T1 (de) 2005-02-10 2006-02-08 Substituierte pyrrole, zusammensetzungen, die diese enthalten, verfahren zur ihrer herstellung und ihre verwendung

Country Status (36)

Country Link
US (1) US7592365B2 (de)
EP (1) EP1851198B1 (de)
JP (1) JP2008530061A (de)
KR (1) KR20070101317A (de)
CN (1) CN101115716A (de)
AR (1) AR052571A1 (de)
AT (1) ATE419234T1 (de)
AU (1) AU2006212106A1 (de)
BR (1) BRPI0606955A2 (de)
CA (1) CA2596822A1 (de)
CR (1) CR9231A (de)
CY (1) CY1108916T1 (de)
DE (1) DE602006004566D1 (de)
DK (1) DK1851198T3 (de)
DO (1) DOP2006000028A (de)
EA (1) EA013060B1 (de)
ES (1) ES2319926T3 (de)
FR (1) FR2881742B1 (de)
GT (1) GT200600048A (de)
HR (1) HRP20090158T1 (de)
IL (1) IL184488A0 (de)
MA (1) MA29248B1 (de)
MX (1) MX2007008789A (de)
MY (1) MY142082A (de)
NO (1) NO20074528L (de)
PA (1) PA8661601A1 (de)
PE (1) PE20061086A1 (de)
PL (1) PL1851198T3 (de)
PT (1) PT1851198E (de)
RS (1) RS50806B (de)
SI (1) SI1851198T1 (de)
TN (1) TNSN07241A1 (de)
TW (1) TW200640858A (de)
UY (1) UY29371A1 (de)
WO (1) WO2006084996A1 (de)
ZA (1) ZA200706157B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
CN101535251B (zh) * 2006-10-23 2012-08-22 莱西肯医药有限公司 5-烷基-7H-吡咯并[2,3-d]嘧啶-2-醇的制备方法
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
CN111132984A (zh) * 2018-08-14 2020-05-08 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
EP3886854A4 (de) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
EP1436279B8 (de) * 2001-09-21 2008-10-29 Smithkline Beecham Corporation Chemische verbindungen
EP1436265A4 (de) 2001-09-27 2004-12-15 Smithkline Beecham Corp Chemische verbindungen
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
US7456190B2 (en) * 2003-03-13 2008-11-25 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
CR9231A (es) 2007-10-23
UY29371A1 (es) 2006-10-02
AU2006212106A1 (en) 2006-08-17
ZA200706157B (en) 2008-11-26
EP1851198B1 (de) 2008-12-31
EP1851198A1 (de) 2007-11-07
PL1851198T3 (pl) 2009-06-30
EA200701688A1 (ru) 2007-12-28
ES2319926T3 (es) 2009-05-14
JP2008530061A (ja) 2008-08-07
RS50806B (sr) 2010-08-31
WO2006084996A1 (fr) 2006-08-17
EA013060B1 (ru) 2010-02-26
FR2881742B1 (fr) 2007-09-07
TW200640858A (en) 2006-12-01
DOP2006000028A (es) 2006-09-15
MX2007008789A (es) 2007-09-11
US20080167368A1 (en) 2008-07-10
HRP20090158T1 (hr) 2009-05-31
AR052571A1 (es) 2007-03-21
SI1851198T1 (sl) 2009-06-30
DK1851198T3 (da) 2009-05-04
CA2596822A1 (fr) 2006-08-17
IL184488A0 (en) 2007-10-31
BRPI0606955A2 (pt) 2009-07-28
US7592365B2 (en) 2009-09-22
PT1851198E (pt) 2009-03-26
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
TNSN07241A1 (en) 2008-11-21
GT200600048A (es) 2006-07-03
CN101115716A (zh) 2008-01-30
PE20061086A1 (es) 2006-11-30
FR2881742A1 (fr) 2006-08-11
NO20074528L (no) 2007-10-31
MY142082A (en) 2010-08-30
PA8661601A1 (es) 2006-09-08
CY1108916T1 (el) 2014-07-02
DE602006004566D1 (de) 2009-02-12

Similar Documents

Publication Publication Date Title
ATE477799T1 (de) Substituierte pyrazolopyridine, diese enthaltende zusammensetzungen, verfahren zur herstellung davon sowie deren verwendung
ATE441638T1 (de) 4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE602004015907D1 (de) Konjugierte Dienamide, Verfahren zur deren Herstellung, diese enthaltende Zusammensetzungen sowie deren Verwendung
ATE470666T1 (de) Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE381564T1 (de) Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
DE602006020386D1 (de) Duraimplantat und Verfahren zu seiner Herstellung
ATE469957T1 (de) Verfahren zur herstellung von ölzusammensetzungen
DE602005020467D1 (de) Dielektrische luneberglinse und verfahren zu ihrer herstellung
ATE490256T1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE602004012796D1 (de) Dichtungsprofil, Verfahren zu seiner Herstellung und Formwerkzeug zur Verwendung in diesem Verfahren
ATE348609T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE502006005961D1 (de) Endoskop und Verfahren zu seiner Herstellung
ATE535510T1 (de) Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel
EP1732985A4 (de) Verfahren zur herstellung von poly(arylenether)zusammensetzungen
EP1906468A4 (de) Batteriedose und verfahren zu ihrer herstellung
ATE461266T1 (de) Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung
ATE517092T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE502006001281D1 (de) Verfahren zur herstellung substituierter biphenyle
ATE471930T1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
DE602005018911D1 (de) 1,4-Dihydropyridine-kondensierte Heterocyclen Verfahren zu deren Herstellung sowie Verwendung und Zusammensetzungen dergleichen
IL184488A0 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
ATE488508T1 (de) Verfahren zur herstellung von irbesartan und zwischenprodukte davon
ATE548030T1 (de) Zusammensetzung mit langsamer freisetzung von fe salzen, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1851198

Country of ref document: EP